Delivery Order SPE2DB22D3501-SPE2DB23FXD73
Award Date 9/8/23
Potential Completion Date 9/29/23
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,358.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg capsules of Ingrezza to treat tardive dyskinesia. As the prime contractor, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania under a contract running from August 18 to September 11, 2023. No subcontractors or set aside designations were specified. This order is likely in support of the Defense Health Agency's mission to provide...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg on September 17, 2025, with completion scheduled for October 8, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of INGREZZA 40 mg, a medication used to treat tardive dyskinesia in patients with schizophrenia or bipolar disorder. This firm fixed price delivery order, valued at $15,056.06, was competitively awarded without set-aside provisions and is scheduled for completion by August 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg, a medication used to treat involuntary movements associated with tardive dyskinesia. This firm fixed-price contract, awarded on September 18, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used primarily for the treatment of tardive dyskinesia, a neurological movement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a non-competitive delivery order against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a $8,022 delivery order to Amerisourcebergen Drug Corporation for 60 mg capsules of Ingrezza. The firm fixed price order is under the Defense Logistics Agency's pharmaceuticals contract vehicle and calls for 30 capsules to be delivered to a facility in Conshohocken, Pennsylvania between July 7 and July 28, 2023. Amerisourcebergen will serve as the prime contractor to supply the neurological drug to the Defense Logistics Agency, which manages the Department of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules in a 30-count package, valued at $8,055.38. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's primary location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). The order represents a non-competitive, firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance will be completed by December 3, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. Ingrezza is...